179 related articles for article (PubMed ID: 21789713)
1. Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis.
Vinall RL; Mahaffey CM; Davis RR; Luo Z; Gandour-Edwards R; Ghosh PM; Tepper CG; de Vere White RW
Horm Cancer; 2011 Aug; 2(4):224-38. PubMed ID: 21789713
[TBL] [Abstract][Full Text] [Related]
2. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
Ma J; Huang H; Han Z; Zhu C; Yue B
Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
Sarwar M; Sandberg S; Abrahamsson PA; Persson JL
Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945
[TBL] [Abstract][Full Text] [Related]
4. Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer.
Thompson VC; Hurtado-Coll A; Turbin D; Fazli L; Lehman ML; Gleave ME; Nelson CC
Prostate; 2010 Jul; 70(10):1134-45. PubMed ID: 20503398
[TBL] [Abstract][Full Text] [Related]
5. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.
Liu S; Vinall RL; Tepper C; Shi XB; Xue LR; Ma AH; Wang LY; Fitzgerald LD; Wu Z; Gandour-Edwards R; deVere White RW; Kung HJ
Oncogene; 2008 Jan; 27(4):499-505. PubMed ID: 17653089
[TBL] [Abstract][Full Text] [Related]
7. Regulation of mRNA gene expression of members of the NF-κB transcription factor gene family by angiotensin II and relaxin 2 in normal and cancer prostate cell lines.
Domińska K; Kowalska K; Matysiak ZE; Płuciennik E; Ochędalski T; Piastowska-Ciesielska AW
Mol Med Rep; 2017 Jun; 15(6):4352-4359. PubMed ID: 28487955
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer.
Qi W; Morales C; Cooke LS; Johnson B; Somer B; Mahadevan D
Oncotarget; 2015 Dec; 6(39):41976-87. PubMed ID: 26506516
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer.
Tevz G; McGrath S; Demeter R; Magrini V; Jeet V; Rockstroh A; McPherson S; Lai J; Bartonicek N; An J; Batra J; Dinger ME; Lehman ML; Williams ED; Nelson CC
Mol Cell Endocrinol; 2016 Jan; 420():159-68. PubMed ID: 26499396
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
11. The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.
Lamb LE; Zarif JC; Miranti CK
Cancer Res; 2011 Apr; 71(7):2739-49. PubMed ID: 21310825
[TBL] [Abstract][Full Text] [Related]
12. Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer.
Fue M; Miki Y; Takagi K; Hashimoto C; Yaegashi N; Suzuki T; Ito K
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126180
[TBL] [Abstract][Full Text] [Related]
13. Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells.
Domińska K; Ochędalski T; Kowalska K; Matysiak-Burzyńska ZE; Płuciennik E; Piastowska-Ciesielska AW
Int J Oncol; 2016 Jun; 48(6):2619-28. PubMed ID: 27035428
[TBL] [Abstract][Full Text] [Related]
14. PKA and cAMP stimulate proliferation of mouse embryonic stem cells by elevating GLUT1 expression mediated by the NF-κB and CREB/CBP signaling pathways.
Kim MO; Lee YJ; Park JH; Ryu JM; Yun SP; Han HJ
Biochim Biophys Acta; 2012 Oct; 1820(10):1636-46. PubMed ID: 22658979
[TBL] [Abstract][Full Text] [Related]
15. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
16. VIP induces NF-κB1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells.
Fernández-Martínez AB; Carmena MJ; Bajo AM; Vacas E; Sánchez-Chapado M; Prieto JC
Cell Signal; 2015 Feb; 27(2):236-44. PubMed ID: 25446255
[TBL] [Abstract][Full Text] [Related]
17. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
[TBL] [Abstract][Full Text] [Related]
18. Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha.
Yin Y; Allen PD; Jia L; MacEy MG; Kelsey SM; Newland AC
Br J Haematol; 2000 Mar; 108(3):565-73. PubMed ID: 10759715
[TBL] [Abstract][Full Text] [Related]
19. Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells.
Li Y; Chinni SR; Sarkar FH
Front Biosci; 2005 Jan; 10():236-43. PubMed ID: 15574364
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
Li Y; Sarkar FH
Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
